BARRIERE-HC®
Roberts
Hydrocortisone – Silicone
Dermatitis Therapy
Indications And Clinical Uses: Adjunctive treatment of allergic dermatoses and other inflammatory skin conditions amenable to topical corticosteroid therapy (e.g., contact, atopic and seborrheic dermatitis, neurodermatitis, psoriasis and anogenital pruritus).
Contra-Indications: Tuberculous and most fungal and viral lesions of the skin, herpes simplex, vaccinia and varicella particularly.
Precautions: Although untoward effects associated with the use of topical corticosteroids are uncommon and not to be expected from ordinary use, sensitization, irritation and failure of therapeutic response have been noted in rare instances. Application to extensive areas, too frequent application, or application under occlusive dressings may result in systemic absorption with symptoms of adrenal suppression, localized atrophy and striae. If secondary bacterial infection exists or supervenes, concomitant antimicrobial therapy is indicated. Do not apply in or near eyes.
Advise patients to inform subsequent physicians of the prior use of corticosteroids.
Pregnancy: Although topical corticosteroids have not been reported to have an adverse effect on pregnancy, the safety of their use during pregnancy has not been established. Therefore, they should not be used extensively on pregnant patients, or in large amounts, or for prolonged periods.
Adverse Reactions: When occlusive dressings are used, pustules, miliaria, folliculitis and pyoderma may occur. The following adverse skin reactions have been reported rarely with the use of topical steroids: dryness, itching, burning, local irritation, striae, hypopigmentation, atrophy and secondary infection.
Dosage: Apply 3 or 4 times a day to affected area. For external use only.
Availability And Storage: Each tube contains: hydrocortisone 1% in a silicone vanishing cream base. Also contains parabens. Cartoned tubes of 15 and 45 g.
BARRIERE-HC® Roberts Hydrocortisone – Silicone Dermatitis Therapy
Posted by RxMed